These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33057926)

  • 1. EphA1 Activation Induces Neuropathological Changes in a Mouse Model of Parkinson's Disease Through the CXCL12/CXCR4 Signaling Pathway.
    Ma J; Wang Z; Chen S; Sun W; Gu Q; Li D; Zheng J; Yang H; Li X
    Mol Neurobiol; 2021 Mar; 58(3):913-925. PubMed ID: 33057926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson's disease.
    Li Y; Niu M; Zhao A; Kang W; Chen Z; Luo N; Zhou L; Zhu X; Lu L; Liu J
    J Neuroinflammation; 2019 Dec; 16(1):263. PubMed ID: 31831012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR4 and CXCL12 expression is increased in the nigro-striatal system of Parkinson's disease.
    Shimoji M; Pagan F; Healton EB; Mocchetti I
    Neurotox Res; 2009 Oct; 16(3):318-28. PubMed ID: 19551455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EphA1 activation promotes the homing of endothelial progenitor cells to hepatocellular carcinoma for tumor neovascularization through the SDF-1/CXCR4 signaling pathway.
    Wang Y; Yu H; Shan Y; Tao C; Wu F; Yu Z; Guo P; Huang J; Li J; Zhu Q; Yu F; Song Q; Shi H; Zhou M; Chen G
    J Exp Clin Cancer Res; 2016 Apr; 35():65. PubMed ID: 27066828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR4 knockout induces neuropathological changes in the MPTP-lesioned model of Parkinson's disease.
    Ma J; Dong L; Chang Q; Chen S; Zheng J; Li D; Wu S; Yang H; Li X
    Biochim Biophys Acta Mol Basis Dis; 2023 Feb; 1869(2):166597. PubMed ID: 36368650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL12 and CXCR4 in the Peripheral Blood of Patients with Parkinson's Disease.
    Bagheri V; Khorramdelazad H; Hassanshahi G; Moghadam-Ahmadi A; Vakilian A
    Neuroimmunomodulation; 2018; 25(4):201-205. PubMed ID: 30428473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated α-synuclein mouse model of Parkinson's disease.
    Rauschenberger L; Behnke J; Grotemeyer A; Knorr S; Volkmann J; Ip CW
    Neurobiol Dis; 2022 Sep; 171():105798. PubMed ID: 35750147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
    Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
    J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
    Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
    J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral inflammation exacerbates α-synuclein toxicity and neuropathology in Parkinson's models.
    La Vitola P; Balducci C; Baroni M; Artioli L; Santamaria G; Castiglioni M; Cerovic M; Colombo L; Caldinelli L; Pollegioni L; Forloni G
    Neuropathol Appl Neurobiol; 2021 Feb; 47(1):43-60. PubMed ID: 32696999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Decreased Srpk3 Expression and Increased Substantia Nigra Alpha-Synuclein Level in an MPTP-Induced Parkinson's Disease Mouse Model.
    Seo MH; Yeo S
    Mol Neurobiol; 2023 Feb; 60(2):780-788. PubMed ID: 36369636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treadmill exercise produces neuroprotective effects in a murine model of Parkinson's disease by regulating the TLR2/MyD88/NF-κB signaling pathway.
    Koo JH; Jang YC; Hwang DJ; Um HS; Lee NH; Jung JH; Cho JY
    Neuroscience; 2017 Jul; 356():102-113. PubMed ID: 28527958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-asarone protects against MPTP-induced Parkinson's disease via regulating long non-coding RNA MALAT1 and inhibiting α-synuclein protein expression.
    Zhang QS; Wang ZH; Zhang JL; Duan YL; Li GF; Zheng DL
    Biomed Pharmacother; 2016 Oct; 83():153-159. PubMed ID: 27470562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease.
    Chen J; Mao K; Yu H; Wen Y; She H; Zhang H; Liu L; Li M; Li W; Zou F
    J Neuroinflammation; 2021 Dec; 18(1):295. PubMed ID: 34930303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA HOTAIR promotes α-synuclein aggregation and apoptosis of SH-SY5Y cells by regulating miR-221-3p in Parkinson's disease.
    Sun Q; Zhang Y; Wang S; Yang F; Cai H; Xing Y; Zhou L; Chen S; Wang Y
    Exp Cell Res; 2022 Aug; 417(1):113132. PubMed ID: 35398161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease in
    Han S; Seo MH; Lim S; Yeo S
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroinflammation and protein pathology in Parkinson's disease dementia.
    Kouli A; Camacho M; Allinson K; Williams-Gray CH
    Acta Neuropathol Commun; 2020 Dec; 8(1):211. PubMed ID: 33272323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of osmotin in Parkinson's disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways.
    Park JS; Choe K; Lee HJ; Park TJ; Kim MO
    J Biomed Sci; 2023 Aug; 30(1):66. PubMed ID: 37568205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease.
    Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L
    Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-let-7a suppresses α-Synuclein-induced microglia inflammation through targeting STAT3 in Parkinson's disease.
    Zhang J; Dongwei Zhou ; Zhang Z; Xinhui Qu ; Kunwang Bao ; Guohui Lu ; Jian Duan
    Biochem Biophys Res Commun; 2019 Nov; 519(4):740-746. PubMed ID: 31547989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.